Once people realize we as shareholders are fortunate to be along for the ride the better it is. From day one management was focused on making a major splash and becoming extremely wealthy. The path path they chose involved allowing others to tag along—not because they wanted us or needed us but because when you go public by merging into an existing ticker and doing it via public disclosures there will be those who jump above because of the DD available.
Bottom Line: SOLI never needed us (the shareholders who discovered their plan) to become a major player in the telemedicine sector. We owe a lot to Smitter, MWM, et al wh discovered the p,an back in late 2018 and early 2019. Some of us have stuck it out. While some have left what has remained is SOLI’s plan. They have continually executed their business plan, continually growing and adding staff.
The SEC definitely threw a wire into the plan with their overreach. One poorly written PR has somewhat delayed their plan as it pertains to share price; however it hasn’t derailed their growth. The number of employees added since April 2020 is huge. The markets they’ve entered (Stare of NY, San Diego, etc) are substantial.
Eventually all the dust will settle. Financials will be filed. SOLI will be back on the OTC. The name change will go into effect. And most importantly the share price will reflect the substance.
Now what will that number be? It wouldn’t surprise me to be 10% of what TDO$ is trading at. Are share structure is amazing. Restricted shares add confidence.
From being here since March ‘19 I can definitely see waking up in May or June and seeing’s a price of $15-20 a share. All the DD points to such a valuation. While I may not like the silent approach of management they have more to gain than I do so I’ll follow along.
